Riskpilot← Back to searchSign inGet full accessPharmion AB
ABIn liquidationOrg 5566222617Economic activity was not specified by tax authority · NACE 0000Est. 20020 employees
Revenue 2006
SEK 0
EBITDA margin
—
+43% vs 2005
Equity ratio
23.3%
Financial strength
Net profit 2006
SEK -13K
+43% vs 2005
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | +43% |
| Net profit | SEK -13K | +43% |
| Total assets | SEK 60K | +11% |
| Equity | SEK 14K | -50% |
| Employees | 0 | — |
Legal name
Pharmion AB
Org number
5566222617
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
17 januari 2002
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2006-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva distribution av all slags läkemedel (även till sjukhus), marknadsstöd till tillverkare av läkemedel (inkluderande men ej begränsat till demonstration av läkemedel till receptutfärdare, samt deltagande i mässor), och till forskningsledare inom kliniker bedrivna av forskningsorganisationer samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2002 | 2003 | 2004 | 2005 | 2006 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −39 | −12 | — | −23 | −13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −39 | −12 | 0 | −23 | −13 |
| Net financials | 1 | — | — | — | — |
| Profit before tax | −38 | −12 | 0 | −23 | −13 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −38 | −12 | 0 | −23 | −13 |
| Item | 2002 | 2003 | 2004 | 2005 | 2006 |
|---|---|---|---|---|---|
| Total assets | 101 | 155 | 92 | 54 | 60 |
| Equity | 62 | 50 | 51 | 28 | 14 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 39 | 104 | 41 | 26 | 45 |
| Total debt | 39 | 104 | 41 | 26 | 45 |
EBITDA margin
-1300000.0%
This company
15.8%
Market median
-8227948% vs market
20022006
Equity ratio
23.3%
This company
38.2%
Market median
-39% vs market
20022006
Return on equity
-92.9%
This company
18.4%
Market median
-605% vs market
20022006
Net profit margin
-1300000.0%
This company
8.1%
Market median
-16049483% vs market
20022006
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20022006
Debt / equity
3.29×
This company
0.62×
Market median
-431% vs market
20022006
- Annual report 2006Filed via Bolagsverket / SCB · Period 2006-01-01 – 2006-12-31
- Annual report 2005Filed via Bolagsverket / SCB · Period 2005-01-01 – 2005-12-31
- Annual report 2004Filed via Bolagsverket / SCB · Period 2004-01-01 – 2004-12-31
- Annual report 2003Filed via Bolagsverket / SCB · Period 2003-01-01 – 2003-12-31
- Annual report 2002Filed via Bolagsverket / SCB · Period 2002-01-01 – 2002-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SG Liquidator | Liquidator | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmion AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sten Gunnar Henning Lindskog | Liquidator | 0 companies |